BG Medicine, Inc. (BGMD) Posts Q4 Loss of 23c/Share, Narrower than Views

BG Medicine, Inc. (NASDAQ: BGMD) reported Q4 EPS of ($0.23), $0.06 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $379 thousand versus the consensus estimate of $250 thousand.

For earnings history and earnings-related data on BG Medicine, Inc. (BGMD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Azitra, Inc. (AZTR) Tops Q2 EPS by 54c
• Jefferies upgrades Five Below to Buy, sees path to TJX-like re-rating